Chemicals & Advanced Materials Global On demand · 24-48h

Global Gamma-Polyglutamic Acid Market Strategic Research Report

Global Gamma-Polyglutamic Acid Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Gamma-Polyglutamic Acid Market
$5182025
7.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Molecular Weight Below 20, 000, 700, 000 Molecular Weight, 1 million Molecular Weight, Above 1.5 million Molecular Weight

By Application: Fertilizer, Medicines & Health Products, Food & Drinks, Cosmetic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Vedan Biotechnology, Bioleaders, Ichimaru Pharcos, Toyobo, Shandong Freda, Nanjing Shineking Biotech, Bloomage Biotech, Guanghua Group, Nanjing Sai Taisi Biotechnology, Zytex, Shandong Changrui, Shandong Taihe Biotech, Lion King Biotechnology, Guangdong Sungen Bioscience, Hefei Hechen

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 124 pages
Market size 2025
$518
Million USD
Forecast CAGR
7.2%
2025-2032
Forecast 2032
$842.7
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Gamma-Polyglutamic Acid market size is predicted to grow from US$ 518 million in 2025 to US$ 840 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.

Gamma-Polyglutamic Acid (γ-PGA) is a naturally occurring, biodegradable, and water-soluble biopolymer composed of glutamic acid monomers linked through γ-amide bonds. Unlike typical proteins that are linked via α-peptide bonds, γ-PGA features γ-linkages between the amino group of one glutamic acid and the carboxyl group on the side chain of another. It is primarily produced through microbial fermentation, especially by Bacillus subtilis and related strains.

Global key players of Gamma-Polyglutamic Acid include Nanjing Shineking Biotech, Vedan Biotechnology, Shandong Changrui, Bloomage Biotech, Shandong Freda, etc. The top five players hold a share about 40%. In terms of product type, 700,000 Molecular Weight is the largest segment, occupied for a share of about 44%, and in terms of application, Fertilizer has a share about 33 percent.

As a bio-based material, the application prospect of Gamma-Polyglutamic Acid is promising. Attracted by the good market prospect, the number of companies deploying this market continues to increase. As far as the Chinese market is concerned, there are more than 20 polyglutamic acid production enterprises with relatively large production capacity, but due to the limitation of the production process, the actual output of polyglutamic acid is relatively low. As a biodegradable green polymer material, polyglutamic acid has attracted more and more attention. Whether it is inside the human body or in the external environment, its final catabolism product is glutamic acid, which has no toxic and side effects on the human body. Polyglutamic acid has shown superiority in many fields. In the future, driven by supply-side reforms and green environmental protection policies, downstream pharmaceuticals, cosmetics, agriculture and other fields need to continuously upgrade their industrial structures, and the market demand for polyglutamic acid will continue to grow accordingly.

This report presents a comprehensive overview of the global Gamma-Polyglutamic Acid market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Molecular Weight Below 20,000
  • 700,000 Molecular Weight
  • 1 million Molecular Weight
  • Above 1.5 million Molecular Weight

Segment by Application

  • Fertilizer
  • Medicines & Health Products
  • Food & Drinks
  • Cosmetic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gamma-Polyglutamic Acid market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Fertilizer, Medicines & Health Products, Food & Drinks evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Gamma-Polyglutamic Acid Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$518
2025
Forecast
$842.7
2032
CAGR
7.2%
2025–2032
Regionen
5
global
Key companies
Vedan BiotechnologyBioleadersIchimaru PharcosToyoboShandong FredaNanjing Shineking BiotechBloomage BiotechGuanghua Group
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Molecular Weight Below 20000700000 Molecular Weight1 million Molecular WeightAbove 1.5 million Molecular Weight
By Application
FertilizerMedicines & Health ProductsFood & DrinksCosmeticOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Molecular Weight Below 20,000
  • 3.1.3 700,000 Molecular Weight
  • 3.1.4 1 million Molecular Weight
  • 3.1.5 Above 1.5 million Molecular Weight
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Fertilizer
  • 4.1.3 Medicines & Health Products
  • 4.1.4 Food & Drinks
  • 4.1.5 Cosmetic
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Vedan Biotechnology
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Bioleaders
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Ichimaru Pharcos
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Toyobo
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Shandong Freda
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Nanjing Shineking Biotech
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Bloomage Biotech
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Guanghua Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Nanjing Sai Taisi Biotechnology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Zytex
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shandong Changrui
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shandong Taihe Biotech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Lion King Biotechnology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Guangdong Sungen Bioscience
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hefei Hechen
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Gamma-Polyglutamic Acid market?
The global Gamma-Polyglutamic Acid market is estimated at US$ 518 million in 2025 (base year) and is projected to reach US$ 840 million by 2032.
What is the forecast CAGR for the Gamma-Polyglutamic Acid market?
The market is expected to grow at a CAGR of 7.2% from 2026 to 2032, expanding from US$ 518 million in 2025 to US$ 840 million in 2032, roughly 1.6 times its base-year value.
What is Gamma-Polyglutamic Acid?
Gamma-Polyglutamic Acid (γ-PGA) is a naturally occurring, biodegradable, and water-soluble biopolymer composed of glutamic acid monomers linked through γ-amide bonds. Unlike typical proteins that are linked via α-peptide bonds, γ-PGA features γ-linkages between the amino group of one glutamic acid and the carboxyl group on the side chain of another. It is primarily produced through microbial fermentation, especially by Bacillus subtilis and related strains.
What are the main segments of the Gamma-Polyglutamic Acid market by type?
By type, the market is segmented into Molecular Weight Below 20,000, 700,000 Molecular Weight, 1 million Molecular Weight and Above 1.5 million Molecular Weight.
Which applications drive demand in the Gamma-Polyglutamic Acid market?
Key applications covered include Fertilizer, Medicines & Health Products, Food & Drinks, Cosmetic and Others.
Who are the key players in the Gamma-Polyglutamic Acid market?
Key players profiled include Vedan Biotechnology, Bioleaders, Ichimaru Pharcos, Toyobo, Shandong Freda, Nanjing Shineking Biotech, Bloomage Biotech and Guanghua Group, among 15 companies covered in total.
Which regions and countries are covered for Gamma-Polyglutamic Acid?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Gamma-Polyglutamic Acid market?
In the future, driven by supply-side reforms and green environmental protection policies, downstream pharmaceuticals, cosmetics, agriculture and other fields need to continuously upgrade their industrial structures, and the market demand for polyglutamic acid will continue to grow accordingly.
Who should buy the Gamma-Polyglutamic Acid market report?
The report is intended for manufacturers and solution providers, distributors and end users in Fertilizer, Medicines & Health Products and Food & Drinks, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Gamma-Polyglutamic Acid market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.